Biotechnology Pharmaceuticals

Turkey Pharmaceutical Industry Statistics

Turkey’s pharma exports reached $1.82B in 2023 (+22%). Generic drugs were $1.1B—explore what’s driving the surge.

Biopharma Industry Statistics

Gene therapy is forecast to grow to $250.0B by 2023—plus 17% of biopharma trials are adding decentralization. See the numbers.

Bio Industry Statistics

Bioeconomy market size reached $307.3B in 2022—while biopharma funding fell 11% YoY in 2023. Explore the signals shaping bio industry investment.

Hydrocodone Statistics

10.1 million U.S. residents aged 12+ misused prescription pain relievers in the past year—hydrocodone is among the opioids involved.

Bio Healthcare Industry Statistics

Oncology trials drove 38% of biotech’s 2023 studies—explore the Bio Healthcare Industry stats behind what’s moving fastest.

Vaccine Industry Statistics

13.5B+ COVID-19 vaccine doses were administered worldwide by end-2022—yet 3.2B children missed at least one routine dose. Explore the gap.

Insulin Statistics

WHO estimates 422 million adults worldwide lived with diabetes in 2014—discover why insulin can be essential for type 1 care.

Weight Loss Drugs Food Industry Statistics

U.S. obesity drug prescriptions surged in 2023—see how that demand is reshaping what Americans buy and how food rules respond.

Life Sciences Industry Statistics

Global patent filings hit 250,000 in 2023—discover what this surge signals for innovation, funding, and therapies.

Korea Bio Industry Statistics

Biopharmaceutical exports hit USD 8.7B in 2023 (61% of total)—see what’s driving Korea’s biotech trade momentum and pipeline.

Biotechnology Healthcare Industry Statistics

U.S. biotech VC funding hit USD 35B in 2023—down 30% from the 2022 peak. Explore what’s fueling the next approvals.

Korean Pharmaceutical Industry Statistics

South Korea’s pharma exports reached $12.8 billion in 2023—see how biotech, generics, and key destinations power the figures.

Indian Pharma Industry Statistics

Exports grew 8.5% YoY to $25.39B in FY23—India’s pharma is scaling fast. Explore jobs, R&D, and capacity signals behind the surge.

Us Biotechnology Industry Statistics

US biotechs generated $50B in mRNA vaccine sales in 2022—see the growth metrics, jobs, and funding behind the surge.

Genomics Industry Statistics

Bioinformatics Statistics

With genomics data set to hit 2,800 petabytes by 2030, the page connects research and operational reality to why bioinformatics statistics matter, from 5.5 billion annual U.S. clinical data points from genomic tests to 52% of labs already running cloud workloads. You also get the operational tension behind pipeline design and reuse, including 43% of organizations struggling with cross system integration and workflow practices like Nextflow style reproducible DAG execution that increasingly separate results that can be trusted from those that cannot.

Biotech Pharma Industry Statistics

Biotech and biopharma are accelerating fast as the global biotechnology market is projected to hit $1.26 trillion by 2030 and CDMO growth is forecast at 4.1% annually through 2032. At the same time, investors put $91.0 billion into biotech in 2021 and the FDA keeps tilting approvals toward biologics, making these supply chain and regulatory signals impossible to ignore for anyone tracking what is next in drug development.

Psychedelics Industry Statistics

With 34 US states already offering some legal path to psychedelics by 2024 and consumer interest rising alongside investor and clinician expectations, this page connects regulation, clinical trial outcomes, and real market momentum into one clear snapshot. You will see how safety and rapid effect windows stack up against funding and rollout costs, from NEJM level trial enrollments to projected private payer reimbursement and the global psychedelics market forecast reaching USD 20.9 billion by 2030.

Weight Loss Drug Food Industry Statistics

Obesity drug momentum is exploding, with the global obesity drugs market at $14.3 billion in 2023 forecast to hit $54.5 billion by 2032 and 1,400 plus obesity and weight loss clinical trials underway in 2023, but real world outcomes and access costs are where the tension lives. You will see how trial side effects and weight loss ranges translate into persistence that often drops fast, plus why pharmacy restrictions, shortages, and out of pocket pricing can turn a prescription into a financial hurdle.

Flu Vaccine Effectiveness Statistics

See how flu shots are performing where it matters most in older adults, with vaccine effectiveness climbing from 30% to 37% across recent U.S. seasons for lab confirmed influenza. You will also get the practical tension behind averages, including 54% protection against influenza A H3N2 in children and how effectiveness can wane over months after vaccination.